Kategorien
Aktien

Iterum Therapeutics PLC 1,13 USD +0,89% 

SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
Nasdaq
Börse Nasdaq
ISIN IE00BF3W0Q35
USD
  • Iterum Therapeutics PLC
    Börse Nasdaq
    ISIN IE00BF3W0Q35 WKN: A2JMZP
    Symbol ITRM
    USD
  • ISIN IE00BF3W0Q35 WKN: A2JMZP
    Symbol ITRM
    USD
ISIN IE00BF3W0Q35
WKN A2JMZP
Symbol ITRM
Währung USD
Börse Nasdaq Zeitzone: America/New_York
Marktkapitalisierung 202.970.720 (+- 3%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

208.941.440 oder 197.000.000

Mitarbeiter 29 (+- 52%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

44 oder 14 Mitarbeiter

EBITDA -96.628.000
PEGRatio None
Buchwert 1.706

Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 1,13 USD +0,89% 

34 News & Informationen zur Iterum Therapeutics PLC Aktie

  • ITERUM ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Iterum Therapeutics plc and...
    marketscreener.com

    ITERUM ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Iterum Therapeutics plc and Encourages Investors to Contact the Firm

    Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Iterum Therapeutics plc in the United States… | August 7, 2021

  • ITRM ALERT: Investors with Substantial Losses Have Opportunity to Lead the Iterum Therapeutics plc Class Action Lawsuit
    marketscreener.com

    ITRM ALERT: Investors with Substantial Losses Have Opportunity to Lead the Iterum Therapeutics plc Class Action Lawsuit

    Robbins Geller Rudman & Dowd LLP announces that purchasers of Iterum Therapeutics plc securities between November 30, 2020 and July 23, 2021, inclusive have until October 4, 2021 to seek… | August 6, 2021

  • SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Iterum Therapeutics plc and Encourages...
    marketscreener.com

    SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Iterum Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

    The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Iterum Therapeutics plc for violations of §§10 and 20 of the… | August 6, 2021

  • Iterum Therapeutics to Provide Business Update and Report Second Quarter 2021 Financial Results on August 13, 2021
    marketscreener.com

    Iterum Therapeutics to Provide Business Update and Report Second Quarter 2021 Financial Results on August 13, 2021

    DUBLIN, Ireland and CHICAGO, Aug. 06, 2021 — Iterum Therapeutics plc , a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat… | August 6, 2021

  • Iterum Therapeutics To Provide Business Update And Report Second Quarter 2021 Financial Results On August 13, 2021
    thestreet.com

    Iterum Therapeutics To Provide Business Update And Report Second Quarter 2021 Financial Results On August 13, 2021

    DUBLIN, Ireland and CHICAGO, Aug. 06, 2021 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company

  • Iterum Therapeutics : Pomerantz Law Firm Announces the Filing of a Class Action Against Iterum Therapeutics plc and Certain Officers - ITRM
    marketscreener.com

    Iterum Therapeutics : Pomerantz Law Firm Announces the Filing of a Class Action Against Iterum Therapeutics plc and Certain Officers – ITRM

    NEW YORK, Aug. 5, 2021 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Iterum Therapeutics plc and certain of its officers. The class action,… | August 6, 2021

  • Summit Therapeutics : Acurx Pharmaceuticals Joins the Antimicrobials Working Group
    marketscreener.com

    Summit Therapeutics : Acurx Pharmaceuticals Joins the Antimicrobials Working Group

    WASHINGTON, Aug. 5, 2021 /PRNewswire/ — The Antimicrobials Working Group announced today the addition of Acurx Pharmaceuticals, Inc. to its coalition of companies with the mission to combat… | August 5, 2021

  • 4 Hot Penny Stocks to Watch With High Volume in August
    pennystocks.com

  • Best Penny Stocks to Watch As July Ends? 3 For Your List
    pennystocks.com

  • Iterum Therapeutics PLC (ITRM) Loses 67.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
    zacks.com

    Iterum Therapeutics PLC (ITRM) Loses 67.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

    Iterum Therapeutics PLC (ITRM) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

  • 3 Penny Stocks on Robinhood to Watch if You Like Biotech
    pennystocks.com

  • Iterum Drops as FDA Denies Approval for UTI Treatment
    thestreet.com

    Iterum Drops as FDA Denies Approval for UTI Treatment

    Iterum's oral sulopenem treatment candidate still needs more testing, the FDA said Monday.

  • Mid-Day Market Update: Crude Oil Down 1%; Xenetic Biosciences Shares Spike Higher
    markets.businessinsider.com

    Mid-Day Market Update: Crude Oil Down 1%; Xenetic Biosciences Shares Spike Higher

    Midway through trading Monday, the Dow traded down 0.19% to 34,996.16 while the NASDAQ fell 0.07% to 14,827.27. The S&P also fell, dropping 0….

  • 40 Stocks Moving in Monday's Pre-Market Session
    markets.businessinsider.com

    40 Stocks Moving in Monday's Pre-Market Session

    Gainers Dynatronics Corporation (NASDAQ:DYNT) shares rose 73.6% to $2.24 in pre-market trading after gaining over 9% on Friday. NanoVibronix Inc…

  • Iterum Therapeutics Receives Complete Response Letter From U.S. Food And Drug Administration For Oral Sulopenem
    thestreet.com

    Iterum Therapeutics Receives Complete Response Letter From U.S. Food And Drug Administration For Oral Sulopenem

    DUBLIN, Ireland and CHICAGO, July 26, 2021 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company”), a clinical-stage pharmaceutical company

  • The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
    markets.businessinsider.com

    The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More

    Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was s…

  • Top Penny Stocks to Buy Next Week? 3 to Watch In Summer 2021
    pennystocks.com

  • Are These Hot Penny Stocks Worth Buying Right Now? 7 For Your List
    pennystocks.com

  • SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Iterum Therapeutics plc (ITRM)
    prnewswire.com

    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Iterum Therapeutics plc (ITRM)

    /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Iterum Therapeutics plc (“Iterum” or the “Company”) (NASDAQ: ITRM). Such…

  • SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Iterum Therapeutics Plc (ITRM)
    thestreet.com

    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Iterum Therapeutics Plc (ITRM)

    NEW YORK, July 7, 2021 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Iterum Therapeutics plc (“Iterum” or the “Company”)

  • Biohaven Leaps After Posting $93M Sales for Migraine Drug
    thestreet.com

    Biohaven Leaps After Posting $93M Sales for Migraine Drug

    Biohaven's Nurtec was approved for migraine treatment in February 2020 and for prevention this past May. Q2 sales: $93 million.

  • Trending Reddit Penny Stocks to Buy Now? Take a Look At These 7
    pennystocks.com

  • Advaxis Jumps on Deal to Be Bought by Biosight
    thestreet.com

    Advaxis Jumps on Deal to Be Bought by Biosight

    Advaxis shares advanced after the company agreed to be purchased by peer biotech Biosight of Israel.

  • Iterum Therapeutics Stock: A Speculative Buy Despite Regulatory Risks (NASDAQ:ITRM)
    seekingalpha.com

    Iterum Therapeutics Stock: A Speculative Buy Despite Regulatory Risks (NASDAQ:ITRM)

    Iterum Therapeutics faces uncertainty as the FDA has issued a letter seeking labeling clarification. Click here to see why this stock could be an excellent candidate for a swing play.

  • Iterum Therapeutics Analyst Remains Bullish Despite Concerns Over FDA Letter
    markets.businessinsider.com

    Iterum Therapeutics Analyst Remains Bullish Despite Concerns Over FDA Letter

    A lack of clarity and final decision in the U.S. Food and Drug Administration's (FDA) recent letter to Iterum Therapeutics PLC (NASD…

  • U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.44% By Investing.com
    investing.com

    U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.44% By Investing.com

    U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.44%

  • Mid-Afternoon Market Update: Silver Rises 2%; Alector Shares Spike Higher
    benzinga.com

    Mid-Afternoon Market Update: Silver Rises 2%; Alector Shares Spike Higher

    Toward the end of trading Friday, the Dow traded up 0.46% to 34,792.90 while the NASDAQ rose 0.67% to 14,619.12. The S&P also rose, gaining 0.66% to …

  • Futures Hover At Record High Ahead Of Payrolls, China Tumbles After Commiefest
    zerohedge.com

    Futures Hover At Record High Ahead Of Payrolls, China Tumbles After Commiefest

    ZeroHedge – On a long enough timeline, the survival rate for everyone drops to zero

  • Iterum Therapeutics Provides Regulatory Update
    thestreet.com

    Iterum Therapeutics Provides Regulatory Update

    DUBLIN, Ireland and CHICAGO, July 01, 2021 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company”), a clinical-stage pharmaceutical company

  • Top Penny Stocks to Buy in July? 7 You May Not Know About
    pennystocks.com

  • 24 Stocks Moving in Monday's Pre-Market Session
    markets.businessinsider.com

    24 Stocks Moving in Monday's Pre-Market Session

    Gainers Intellia Therapeutics, Inc. (NASDAQ:NTLA) rose 28.9% to $114.49 in pre-market trading. Intellia Therapeutics and Regeneron Pharmaceutica…

  • 8 Penny Stocks to Watch Right Now As June Comes to an End
    pennystocks.com

  • Iterum Therapeutics (ITRM) Investor Presentation - Slideshow (NASDAQ:ITRM)
    seekingalpha.com

    Iterum Therapeutics (ITRM) Investor Presentation – Slideshow (NASDAQ:ITRM)

    The following slide deck was published by Iterum Therapeutics plc in conjunction with this event.

  • Iterum Therapeutics To Participate In H.C. Wainwright BioConnect Virtual Conference
    thestreet.com

    Iterum Therapeutics To Participate In H.C. Wainwright BioConnect Virtual Conference

    DUBLIN, Ireland and CHICAGO, Jan. 06, 2021 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Dir gefallen die Informationen zu Iterum Therapeutics PLC?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu Iterum Therapeutics PLC?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect

Dir gefallen die Informationen zu Iterum Therapeutics PLC?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba

Dir gefallen die Informationen zu Iterum Therapeutics PLC?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic